The combination of clinical and preclinical findings of the studies included revealed that HOXA3, A9, B7, B8, C6, C11 and D9 were found to be upregulated in CRC tissues [24,25,26,36,40,43]. This evidence concerns the gene HOXA3 and colorectal carcinoma.